Detalhe da pesquisa
1.
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection.
Int J Cancer
; 152(4): 661-671, 2023 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36056571
2.
Corrigendum: Definition of the immune parameters related to COVID-19 severity.
Front Immunol
; 14: 1219179, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37292212
3.
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients.
Cancer Med
; 12(12): 12967-12974, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37114577
4.
Definition of the Immune Parameters Related to COVID-19 Severity.
Front Immunol
; 13: 850846, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35371011